These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 4756402)
1. [Usefulness of Sandomigran in treatment of migraine syndromes]. Wasilewski R Pol Tyg Lek; 1973 Aug; 28(34):1320-1. PubMed ID: 4756402 [No Abstract] [Full Text] [Related]
3. [BC-105 preparation in treatment of migraine]. Zwozdziak W Wiad Lek; 1973 Dec; 26(23):2207-9. PubMed ID: 4588418 [No Abstract] [Full Text] [Related]
4. The treatment of migraine with BC 105 (pizotifen): a double blind trial. Arthur GP; Hornabrook RW N Z Med J; 1971 Jan; 73(464):5-9. PubMed ID: 4925988 [No Abstract] [Full Text] [Related]
5. BC 105 in the prophylaxis of migraine. Hughes RC; Foster JB Curr Ther Res Clin Exp; 1971 Jan; 13(1):63-8. PubMed ID: 4992568 [No Abstract] [Full Text] [Related]
6. [Zung's test for the quantitative assessment of depression and its confirmation during the testing of a new anti-migraine agent Sandomigran]. Klapetek J Cesk Neurol; 1973 Sep; 36(5):298-303. PubMed ID: 4581588 [No Abstract] [Full Text] [Related]
7. [Effect of BC 105 on the depressed mood in migraine]. Müller KH; Haarmann K; Neff K Ther Umsch; 1972 Oct; 29(10):628-35. PubMed ID: 5078775 [No Abstract] [Full Text] [Related]
8. [Differential diagnosis of headache and experiences with a new preparation in the treatment of migraine]. Brügger A Schweiz Rundsch Med Prax; 1970 Sep; 59(39):1360-5. PubMed ID: 5519088 [No Abstract] [Full Text] [Related]
9. [BC-105 in the prevention of migraine]. Ledić P; Antoncić N; Sepcić J Neuropsihijatrija; 1973; 21(3-4):291-6. PubMed ID: 4616184 [No Abstract] [Full Text] [Related]
14. [Experiences with the new serotonin antagonist BC-105 (Sandomigran) in the treatment of migraine]. Schär J Praxis; 1969 Dec; 58(52):1717-22. PubMed ID: 5395692 [No Abstract] [Full Text] [Related]
15. [Zung's test for the quantitative assessment of depression and its confirmation through the testing of a new anti-migraine drug Sandomigran]. Klapetek J Cesk Neurol Neurochir; 1973 Oct; 36(5):298-303. PubMed ID: 4588664 [No Abstract] [Full Text] [Related]
16. [Preventive treatment of migraine using a new antimigraine drug Sandomigran]. Klapetek J Cesk Neurol Neurochir; 1976 Jan; 39(1):28-35. PubMed ID: 1253301 [No Abstract] [Full Text] [Related]
17. Seminar on headache. Can Med Assoc J; 1971 Jul; 105(1):89-92. PubMed ID: 5088482 [No Abstract] [Full Text] [Related]
18. Clinical physiological study of the action of BC 105 (Sandoz, Basle) in the interval therapy of migraine. Starý O; Janský M; Figar S; Stein J Eur Neurol; 1974; 11(6):353-62. PubMed ID: 4604231 [No Abstract] [Full Text] [Related]
19. [Sandomigran (BC-105) in treatment of migraine and Horton's headache]. Prusiński A; Kotwica S; Rydzewski W; Zawadzki Z Neurol Neurochir Pol; 1972; 6(3):427-31. PubMed ID: 5032295 [No Abstract] [Full Text] [Related]
20. A cooperative study on the clinical aspects of migraine and vascular headache and their response to sandomigran. Espadaler JM; Gimeno A; Lage AM Arch Neurobiol (Madr); 1974; 37 SUPPL():206-26. PubMed ID: 4462482 [No Abstract] [Full Text] [Related] [Next] [New Search]